MIR668: A Potential Cancer Drug Target and Biomarker (G768214)
MIR668: A Potential Cancer Drug Target and Biomarker
MIR668, also known as hsa-mir-668, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for various diseases, including cancer. MIR668 is a microRNA (miRNA) that is expressed in a variety of tissues and cells in the body.
The discovery of MIR668 as a potential drug target or biomarker comes from a study by researchers at the University of California, San Diego School of Medicine. The study, published in the journal Nature Medicine in 2012, identified MIR668 as a potential target for cancer treatment using a technique called microarray analysis.
The researchers used microarray analysis to analyze the expression of MIR668 in a variety of cancer cells and tissues. They found that MIR668 was highly expressed in a variety of cancer cells, including breast, ovarian, and prostate cancer cells. The researchers also found that MIR668 was downregulated in cancer cells compared to normal cells, which suggests that it may have a negative impact on cancer cell growth and survival.
In addition to its potential as a cancer drug target, MIR668 has also been identified as a potential biomarker for cancer. The researchers found that MIR668 was downregulated in the tissue samples of cancer patients, which suggests that it may be a useful biomarker for cancer diagnosis and monitoring.
The identification of MIR668 as a potential drug target or biomarker has important implications for the development of cancer treatments. If MIR668 is found to be a reliable drug target, researchers may be able to develop new treatments that specifically target MIR668 and avoid the potential side effects associated with traditional cancer treatments.
In addition, the discovery of MIR668 as a potential biomarker for cancer may have important implications for cancer diagnosis and monitoring. By using MIR668 as a biomarker, researchers may be able to develop new diagnostic tests that can accurately identify cancer at an early stage, when treatment is most effective.
Overall, the discovery of MIR668 as a potential drug target or biomarker for cancer has significant implications for the development of new treatments and the diagnosis and monitoring of cancer. Further research is needed to fully understand the role of MIR668 in cancer biology and to develop effective treatments.
Protein Name: MicroRNA 668
More Common Targets
MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808
